Komori
General Meetings of Shareholders4875MediciNova,Inc.Pharmaceuticals

Notice Regarding Resolutions at the Annual General Meeting of Shareholders

At the annual general meeting of shareholders, Proposal 1, the election of 2 directors; Proposal 2, the appointment of the accounting firm; and Proposal 4, the postponement of the meeting, were approved. Meanwhile, the amendment to the Articles of Incorporation to increase the number of authorized common shares from 100 million to 247 million was rejected.

Worth reading
52Recurring
Scored from 2 of 4 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
147000000
Shares (proposal to increase the number of authorized common shares)
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual General Meeting of Shareholders
2026
Jun 23
Date and time(U.S. Pacific Daylight Time)
Matters for resolution4 items
  1. Election of Class I directors

  2. Approval of the appointment of the independent registered public accounting firm

  3. Approval of amendments to the Restated Certificate of Incorporation

  4. Approval of postponing this annual meeting of shareholders to a later date, if necessary

Shareholder Proposal

None (no description of shareholder proposals)

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nominee2 candidates, including new candidates: Not disclosed; outside directors: Not disclosed
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual General Meeting of Shareholders
Date and time23 June 2026 (U.S. Pacific Daylight Time)
Matters for resolutionProposal 1: Election of Class I directors, Proposal 2: Approval of the appointment of the independent registered public accounting firm, Proposal 3: Approval of amendments to the Restated Certificate of Incorporation, Proposal 4: Approval of postponing this annual meeting of shareholders to a later date, if necessary
Shareholder ProposalNone (no description of shareholder proposals)
Director nominee2 candidates, including new candidates: Not disclosed; outside directors: Not disclosed
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Proposal 4 was intended to postpone the meeting if one or more of the matters submitted for resolution did not receive sufficient votes in favor, or if postponement was otherwise necessary or appropriate in connection with those matters. No reason is given for Proposal 3 not being approved.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Resolutions at the Annual General Meeting of Shareholders | MediciNova,Inc. (4875) timely disclosure | Komori